-
Heavyweight New Rules Live Improvement Drugs: What's Worth Doing? Which ones step on the thunder?
Time of Update: 2020-07-29
Medicine Network July 29th, the much-anticipated technical guide to improved medicines has come! At the end of June, CDE issued the Technical Guidelines for Clinical Trials of Chemical LycintS New Dru
-
A batch of drugs has been evaluated first (with list)
Time of Update: 2020-07-29
Pharmaceutical network July 20, 1, a batch of drugs, over consistency evaluation recently, there are a number of pharmaceutical companies announced that there is a variety consistency evaluation Accor
-
Mid-2020 review: FDA-EMA-33-41 new drugs approved, 20 still rejected; BMS, AbbVie...
Time of Update: 2020-07-29
Read: FDA and EMA 2020 New Drug Approval Profile !---- If you think Covid-19 has delayed approval of new drugs from the U.S Food and Drug Administration (FDA), you're wrong Even as the outbreak sprea
-
The application for a listing license for the new drug Pamipalei of Baiji Shenzhou is included in the priority review.
Time of Update: 2020-07-29
Guide: Pamipali is the third innovative drug developed by Baiji Shenzhou, and has followed in the footsteps of The ® and Bai Yueze ® !---- baiji Shenzhou is a commercial biotech company The company a
-
NEJM Review: How will coffee affect our health?
Time of Update: 2020-07-29
Guide: Drinking 3 to 5 standard cups of coffee a day can reduce the risk of several chronic diseases Coffee and tea are among the most popular beverages in the world !---- Because it contains a lot o
-
Progress has been made in many countries by the intensive release of data from clinical trials of the new crown vaccine.
Time of Update: 2020-07-28
Medicine Network Monthly New Crown outbreak in the global multi-point people are looking for a safe and effective new crown virus vaccine Recent advances in the development of new coronavirus vaccines
-
Nature's latest study: New coronavirus-specific immune T-cells can also be detected in uninfected populations.
Time of Update: 2020-07-28
Guide: Beta coronavirus infection induces the body to produce polyspecific and long-lasting cellular immunity to structural proteins Source: Bio-exploration of new coronal pneumonia caused by the new
-
China's Phase 2 clinical trial of a new coronavirus vaccine achieves good results
Time of Update: 2020-07-28
Chinese researchers said in a paper published in the British medical journal The Lancet that they have conducted clinical trials of a new coronavirus vaccine that show it is safe and induces an immune
-
The best-selling anti-epileptic drug, the Shanghai company's first review
Time of Update: 2020-07-27
Pharmaceutical Network July 23rd, July 20, the official website of the State Drug Administration shows that Shanghai Qingping Pharmaceutical Co., Sodium Valproate tablets through consistency evaluatio
-
Domestic heavy-duty anti-cancer drug Zebutini shines on the scene, East Sunshine Lelotini three-phase research.
Time of Update: 2020-07-21
Zebutinib approved two indications on June 3, 2020, the State Drug Administration through the priority review and approval process with the conditions of the approval of Baiji Shenzhou Class 1 innovat
-
The new lancet consolidates the status of aspirin "god medicine" and can reduce the risk of colorectal cancer for two years.
Time of Update: 2020-07-20
Guide: "The God's Medicine" adds "myths" in scientific research, there is never a lack of "myths" about aspirin Since its birth more than 100 years ago, researchers have been trying to apply the magi
-
More than 5 billion antifungal drugs Shenyang Xingqi eye drug Volikangaodin eye drops clinical application was accepted.
Time of Update: 2020-07-20
Minet data show that many pharmaceutical companies are developing new dosage forms of Voliconazole, including dry suspension, granules, eye drops and so on On June 20, Shenyang Xingqi Eye Medicine to the new drug 2.2 class declared the clinical application of Volikangaoodi eye drops to be accepted by CDE, acceptance number CXHL2000294, Shenyang Xingqi eye medicine for the first layout of Volikangao oozing eye drops enterprise .
-
When will the new crown vaccine be available? What trials are to be completed in Phase III clinically?
Time of Update: 2020-07-20
Wang Junzhi, vice-chairman of the group of experts and academician of the Chinese Academy of Engineering, gave authoritative answers Reporter: What is the effect of the first phase of clinical trial?
-
Amjin osteoporosis drug Proe (R) has been approved in China.
Time of Update: 2020-07-20
Read: Innovative treatment options will benefit postmenopausal women at high risk of fractures! , June 19, 2020 /PRNewswire/ -- Amjin China announces that The pro-® (Prolia ®; generic name: dishua zum
-
Ask the pinnacle! An overview of the research and development pipeline of the anti-tumor drug I-Goroche Pharmaceuticals.
Time of Update: 2020-07-20
Guide: Roche's research and development pipeline focuses on the field of oncology, combined with the future treatment needs of patients, continuous research and development investment, in the existing
-
Analysis of anti-tumor new drug Dayou with the ®: blocking blood vessel support to "starve" tumor
Time of Update: 2020-07-20
Xinda Bio Senior Vice President Yan Hong stressed that Dayou and ® from the project to the listing lasted 8 years, "through a large number of research to establish a scientific and rigorous target." She said that the production of the drug's industrialization base also in line with China's NMPA, the U.S FDA, the European EMA's GMP standards Clinical data show that the drug has good therapeutic effect on advanced non-small cell lung cancer and metastatic colorectal cancer (Complete) .
-
Sanjin New Origin Market What has been found by the China CDC Virus Disease?
Time of Update: 2020-07-20
Medical Network June 19 - June 17 at 8 p.m., a bus in Beijing's Xicheng District, 100 Yingxin Street, the Southern District of the China Center for Disease Control and Prevention virus disease emerg
-
China's first new crown mRNA vaccine has been approved for clinical trials.
Time of Update: 2020-07-19
Qin Chengfeng, project leader and researcher of the Institute of Military Medicine of the Military Academy of Sciences, said that the domestic new crown mRNA vaccine has three advantages: First, the vaccine antigen target selection is more accurate, the induction of neutralizing antibody specificity is high, the vaccine safety is better; .
-
Shanxi and Chinese bio-joint research and development center for vaccines.
Time of Update: 2020-07-18
Pharmaceutical Network, June 30, the evening of June 28, Shanxi Provincial People's Government and China Biotechnology Co., Ltd (hereinafter referred to as "China Biology") signed a framework agreem
-
Not only can it be cured, but it can also be prevented? AstraZeneca Farxiga reduces risk of new diabetes by 32%
Time of Update: 2020-07-18
Read: Farxiga reduced the risk of new type 2 diabetes by nearly a third compared to placebo exploratory analysis of DAPA-HF, the AstraZeneca SGLTT2 inhibitor Farxiga (dapagliflozin), at the 80th Ame
